Literature Cited

  • 1
    Gao YT,Shu XO,Kushi LH,Ruan Z,Bostick RM,Jin F,Zheng W. Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study. Int J Cancer 2000; 87: 295300.
  • 2
    Ring A,Smith IE,Dowsett M. Circulating tumor cells in breast cancer. Lancet Oncol 2004; 5: 7988.
  • 3
    Birchmeier C,Birchmeier W,Gherardi E,Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915925.
  • 4
    Uhr JW,Scheuermann RH,Street NE,Vitetta ES. Cancer dormancy: Opportunities for newtherapeutic approaches. Nat Med 1997; 3: 505509.
  • 5
    Pantel K,Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448456.
  • 6
    Blaqosklonny MV. Target for cancer therapy: Proliferating cells or stem cells. Cancer 2006; 20: 385391.
  • 7
    Martin VM,Siewert C,Scharl A, Harms T, Heinze R, Ohl S, Radbruch A, Miltenyi S, Schmitz J. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998; 26: 252264.
  • 8
    Pachmann K,Heiss P,Demel U,Tilz G. Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC). Clin Chem Lab Med 2001; 39: 811817.
  • 9
    Naume B,Borgen E,Beiske K, Herstad TK, Ravnas G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S, Kvalheim G. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997; 6: 103114.
  • 10
    Ross AA,Cooper BW,Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993; 82: 26052610.
  • 11
    Mesker WE,vd Burg JM,Oud PS,Knepfle CF,Ouwerkerk-v Velzen MC,Schipper NW,Tanke HJ. Detection of immunocytochemically stained rare events using image analysis. Cytometry 1994; 17: 209215.
  • 12
    Pelkey TJ,Frierson HFJr,Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996; 42: 13691381.
  • 13
    Schulze R,Schulze M,Wischnik A, Ehnle S, Doukas K, Behr W, Ehret W, Schlimok G. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 1997; 19: 12231228.
  • 14
    Cote RJ,Beattie EJ,Chaiwun B, Shi SR, Harvey J, Chen SC, Sherrod AE, Groshen S, Taylor CR. Detection of occult bone marrow micrometastasis in patients with operable lung carcinoma. Ann Surg 1995; 4: 415425.
  • 15
    Allan AL,Vantyghem SA,Tuck AB,Chambers AF,Chin-Yee IH,Keeney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry Part A 2005; 65A: 414.
  • 16
    Leather AJ,Gallegos NC,Kocjan G, Savage F, Smales CS, Hu W, Boulos PB, Northover JM, Phillips RK. Detection and enumeration of circulating tumour cell in colorectal cancer. Br J Surg 1993; 80: 777780.
  • 17
    Rosenberg R,Gertler R,Friederichs J,Fuehrer K,Dahm M,Phelps R,Thorban S,Nekarda H,Siewert JR. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002; 49: 150158.
  • 18
    Slade MJ,Smith BM,Sinnett HD, Cross NC, Coombes RC. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999; 17: 870879.
  • 19
    Raynor M,Stephenson S-A,Walsh DCA, Henderson MA, Dobrovic A. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC cancer 2002; 5: 14711480.
  • 20
    Moll R. Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 1994; 9: 6369.
  • 21
    Schaller G,Fuchs I,Pritze W,Ebert A,Herbst H,Pantel K,Weitzel H,Lengyel E. Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer. Clin Cancer Res 1996; 2: 18791885.
  • 22
    Fuchs IB,Lichtenegger W,Buehler H,Henrich W,Stein H,Kleine-Tebbe A,Schaller G. The prognostic significance of epithelial-mesenchymal transition in breast cancer. Anticancer Res 2002; 22: 34153419.
  • 23
    Gotzmann J,Mikula M,Eger A,Schulte-Hermann R,Foisner R,Beug H,Mikulits W. Molecular aspects of epithelial cell plasticity: Implications for local tumor invasion and metastasis. Mutat Res 2004; 566: 920.
  • 24
    Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442454.
  • 25
    Racila E,Euhus D,Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998; 95: 45894594.
  • 26
    Gross HJ,Verwer B,Houck D, Hoffman RA, Recktenwald D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc Natl Acad Sci USA 1995; 92: 537541.
  • 27
    Palomares MR,Richardson-Lander A,Koehler KM, Gralow JR, Sabath DE. Quantitative real-time RT-PCR for the detection of circulating breast cancer cells: Correlation with stage and treatment. In: Proceedings of 26th Annual San Antonio Breast Cancer Symposium, 2002; abstract 217.
  • 28
    Budd GT,Cristofanilli M,Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF. Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12: 64036409.
  • 29
    Cristofanilli M,Budd GT,Ellis M, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells predict progression free survival and overall survival in metastatic breast cancer. N Engl J Med 2004; 351: 781791.